Catalyst Repository | Flexion Therapeutics Inc. Common Stock

Flexion Therapeutics Inc. Common Stock

(NASDAQ:FLXN)

Description

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.

FLXN Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$11.0800
Previous Close Volume
419345